WHO REMAIN DISEASE-FREE

Clinical trials for WHO REMAIN DISEASE-FREE explained in plain language.

Never miss a new study

Get alerted when new WHO REMAIN DISEASE-FREE trials appear

Sign up with your email to follow new studies for WHO REMAIN DISEASE-FREE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a targeted drug keep High-Risk breast cancer from returning?

Disease control Ongoing

This phase III trial is testing whether adding the drug everolimus to standard hormone therapy can help prevent breast cancer from coming back in women with ER-positive, HER2-negative breast cancer who are at high risk of relapse. Participants have already completed at least one …

Matched conditions: WHO REMAIN DISEASE-FREE

Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC

WHO REMAIN DISEASE-FREE

Get alerted when new WHO REMAIN DISEASE-FREE trials appear

Can a targeted drug keep High-Risk breast cancer from returning?